Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Investigate Which Altcoins Have Practical Use Cases by focusing on real applications, partnerships, and user adoption to guide choices.
27,754 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Chinese firms are shifting away from Nvidia’s AI accelerators toward domestic suppliers, a move driven by policy aims...
A bold move by Berkshire Hathaway’s new leadership shifted power in the tech landscape. This is how Greg Abel built b...
The Supreme Court invalidated President Trump's global tariffs in a 6-3 decision. He vows to impose new duties under ...
A broad selloff descends into rout in South Korea, sending the KOSPI to its worst daily decline in 16 years. Margin c...
The U.S. DOJ moves to retry Tornado Cash developer Roman Storm on key charges in SDNY, aiming to resolve unresolved c...
A quarterly filing reveals Adams Wealth Management reduced its holdings in the iShares AAA CLO Active ETF (CLOA). The...
In 2022, the 3x levered ETF SOXL plunged about 90%, even as the broader semiconductor group endured a mid-cycle decli...
CoreWeave's backlog booming has caught the eye of investors eyeing AI infrastructure. This piece breaks down whether ...
The Supreme Court voided emergency tariff powers, pushing the administration to a Section 301 strategy aimed at a dur...
A fresh NAHB study finds regulatory costs have raised the typical new-home price by about $131,734, representing 26.4...
In a choppy market, a dependable income stock is turning heads in 2026. This article breaks down why this resilient d...